Embryo implantation into the uterine wall is a highly regulated and vital event of early mammalian development. Following hatching from the zona pellucida, the trophectodermal cells surrounding the embryo develop to an attachment competent state. Attachment competent embryos are capable of attaching to and invading a wide variety of cell and tissue types (1-3). The uterus appears to be unique in the sense that it is the only known tissue capable of regulating the invasive potential of the trophoblast. Under most conditions, the uterus is """"""""non-receptive"""""""" and will not allow embryos to attach. Conversion to a receptive uterine state is transient and normally coordinated with the development of the embryo by the actions of estrogen and progesterone (4). The task of regulating the uterine receptivity is relegated to the cells lining the uterine lumen, the uterine epithelial cells (UEC). In this regard, a number of morphological studies indicate that the composition of cell surface polysaccharides alters dramatically on both trophectodermal and UEC cell surfaces at the time of embryo attachment. These observations are consistent with an important role for cell surface glycoconjugates in embryo-UEC interactions. Heparan sulfate proteoglycans (HSPGs) are glycoconjugates distributed on cell surfaces and in extracellular matrices of many cell and tissue types (6-8). The constituent polysaccharides of HSPGs appear to participate in or modulate a variety of biological processes including anticoagulation, growth factor binding, regulation of cell proliferation and metabolism and cell adhesion (6-8). With regard to embryo implantation, work in the principal investigator's lab indicates that HSPGs on the embryo cell surface and corresponding HS-binding proteins (HSBPs) of the cell surface of UEC participate in cell adhesion processes occurring in between these cell types in mouse and human model systems. Our hypothesis is that appropriate expression of HS structures and the corresponding HSBPs is critical for trophoblast-UEC interactions. This proposal will employ biochemical, molecular biological and immunochemical approaches to stud), HS-dependent interactions in the initial phase of embryo-UEC binding in vitro and in vivo in mouse and human models. Collectively, these studies will address the molecular basis of embryo-uterine interactions.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025235-05
Application #
3326273
Study Section
Reproductive Biology Study Section (REB)
Project Start
1988-12-01
Project End
1997-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
5
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Other Domestic Higher Education
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Oristian, Daniel S; Sloofman, Laura G; Zhou, Xiaozhou et al. (2009) Ribosomal protein L29/HIP deficiency delays osteogenesis and increases fragility of adult bone in mice. J Orthop Res 27:28-35
D'Souza, Sonia S; Fazleabas, Asgerally T; Banerjee, Prajna et al. (2008) Decidual heparanase activity is increased during pregnancy in the baboon (Papio anubis) and in in vitro decidualization of human stromal cells. Biol Reprod 78:316-23
Farach-Carson, Mary C; Carson, Daniel D (2007) Perlecan--a multifunctional extracellular proteoglycan scaffold. Glycobiology 17:897-905
D'Souza, Sonia S; Daikoku, Takiko; Farach-Carson, Mary C et al. (2007) Heparanase expression and function during early pregnancy in mice. Biol Reprod 77:433-41
Kirn-Safran, Catherine B; Oristian, Daniel S; Focht, Richard J et al. (2007) Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev Dyn 236:447-60
Liu, Jian-Jun; Zhang, Jinqiu; Ramanan, Sriram et al. (2004) Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs. Carcinogenesis 25:873-9
Reiland, Jane; Sanderson, Ralph D; Waguespack, Marian et al. (2004) Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 279:8047-55
Miller, Stephanie A; Brown, Anissa J; Farach-Carson, Mary C et al. (2003) HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation. Differentiation 71:322-36
Ta, T-V; Baraniak, D; Julian, J et al. (2002) Heparan sulfate interacting protein (HIP/L29) negatively regulates growth responses to basic fibroblast growth factor in gingival fibroblasts. J Dent Res 81:247-52
Carson, Daniel D (2002) The glycobiology of implantation. Front Biosci 7:d1535-44

Showing the most recent 10 out of 40 publications